Ross Leonard S 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
Ross Leonard S
Corporate Controller
Transactions
- Tax Payment
Common Stock
2019-06-14$1.53/sh−2,394$3,663→ 85,338 total - Exercise/Conversion
Common Stock
2019-06-14+8,280→ 87,732 total - Exercise/Conversion
Restricted Stock Units
2019-06-14−8,280→ 16,560 totalExercise: $0.00→ Common Stock (8,280 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
- [F3]On June 14, 2018, the reporting person was granted 24,840 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.